Placental determinants of fetal growth: Identification of key factors in the insulin-like growth factor and cytokine systems using artificial neural networks

被引：32

作者：

Street M.E. ^{[1
]}

Grossi E. ^{[2
]}

Volta C. ^{[1
]}

Faleschini E. ^{[3
]}

Bernasconi S. ^{[1
]}

机构：

[1] Department of Pediatrics, University of Parma

[2] Centro Diagnostico Italiano, Milan, Via Saint Bon

[3] Department of Pediatrics, I.R.C.C.S Burlo Garofalo, Trieste

来源：

BMC Pediatrics | / 8卷 / 1期

关键词：

Fetal Growth; Back Propagation; Fetal Growth Restriction; Input Selection; Fetal Growth Restriction;

D O I：

10.1186/1471-2431-8-24

中图分类号：

学科分类号：

摘要：

Background: Changes and relationships of components of the cytokine and IGF systems have been shown in placenta and cord serum of fetal growth restricted (FGR) compared with normal newborns (AGA). This study aimed to analyse a data set of clinical and biochemical data in FGR and AGA newborns to assess if a mathematical model existed and was capable of identifying these two different conditions in order to identify the variables which had a mathematically consistent biological relevance to fetal growth. Methods: Whole villous tissue was collected at birth from FGR (N = 20) and AGA neonates (N = 28). Total RNA was extracted, reverse transcribed and then real-time quantitative (TaqMan) RT-PCR was performed to quantify cDNA for IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IL-6. The corresponding proteins with TNF-α in addition were assayed in placental lysates using specific kits. The data were analysed using Artificial Neural Networks (supervised networks), and principal component analysis and connectivity map. Results: The IGF system and IL-6 allowed to predict FGR in approximately 92% of the cases and AGA in 85% of the cases with a low number of errors. IGF-II, IGFBP-2, and IL-6 content in the placental lysates were the most important factors connected with FGR. The condition of being FGR was connected mainly with the IGF-II placental content, and the latter with IL-6 and IGFBP-2 concentrations in placental lysates. Conclusion: These results suggest that further research in humans should focus on these biochemical data. Furthermore, this study offered a critical revision of previous studies. The understanding of this system biology is relevant to the development of future therapeutical interventions possibly aiming at reducing IL-6 and IGFBP-2 concentrations preserving IGF bioactivity in both placenta and fetus. © 2008 Street et al; licensee BioMed Central Ltd.

引用

共 47 条

[1]

Resnik R., Intrauterine growth restriction, Obs Gynecol, 99, pp. 490-496, (2002)

[2]

Karlberg J., Albertsson-Wikland K., Growth in full-term small-for-gestational-age infants: From birth to final height, Pediatr Res, 38, pp. 733-739, (1995)

[3]

Godfrey K.M., Barker D.J., Fetal nutrition and adult disease, Am J Clin Nutr, 71, (2000)

[4]

DeChiara T.M., Robertson E.J., Efstratiadis A., A growth-deficient phenotype in heterozygous mice carrying an insulin-like growth factor-II gene disrupted by targeting, Nature, 344, pp. 78-80, (1990)

[5]

Baker J., Liu J.-P., Robertson E.J., Efstratiadis, A Role of Insulin-like Growth factors in embryonic and Postnatal Growth, Cell, 75, pp. 73-82, (1993)

[6]

Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis, A Mice carrying null mutations of the genes encoding insulin-like growth factor-I (IGF-I) and Type-1 IGF Receptor (Igf1r), Cell, 75, pp. 59-72, (1993)

[7]

Ohlsson R., Holmgren L., Glaser A., Szpecht A., Pfeifer-Ohlsson S., Insulin-like growth factor 2 and short-range stimulatory loops in control of human placental growth, The EMBO Journal, 8, pp. 1993-1999, (1989)

[8]

Shen S.J., Wang C.-Y., Nelson K.K., Jansen M., Ilan J., Expression of insulin-like growth factor II in human placentas from normal and diabetic pregnancies, Proc Natl Acad Sci USA, 83, pp. 9179-9182, (1986)

[9]

Wang C.-Y., Daimon M., Shen S.-J., Engelman G.L., Ilan J., Insulin-Like Growth Factor-I Messenger RibonucleicAcid in the Developing Human Placenta and in Term Placenta of Diabetics, Mol Endocrinol, 2, pp. 217-229, (1998)

[10]

Zollers W.G., Babischkin J.S., Pepe G.J., Albrecht E.D., Developmental Regulation of Placental Insulin-Like Growth Factor (IGF)-II and IGF-Binding Protein-1 and -2 Messenger RNA Expression During Primate Pregnancy, Biol Reprod, 165, pp. 1208-1214, (2001)

← 1 2 3 4 5 →